Ludwig A. Lettau, MD
This content is PDF only. Please click on the PDF icon to access.
The Glitze Pharmaceuticals rep entered my office at the appointed hour and greeted me with a triumphant smile. In my mind I was already hearing a drum roll and trumpet fanfare heralding something wonderful. Rep: "Dr. Lettau, I appreciate this opportunity to present our new sixth-generation cephalosporin, Cefaholygrail. Its spectrum of activity is not just broad, it's universal. It covers all gram positives including resistant staph and enterococcus, all gram negatives including Pseudomonas, all anaerobes, and even chlamydia and rickettsia."
Dr: "I'll bet that coverage includes the flora inhabiting the lower backside of the prescriber. Hmmm, includes rickettsia you say-you
Lettau LA. Antibiotics 1999. Ann Intern Med. 1989;110:850. doi: https://doi.org/10.7326/0003-4819-110-10-850
Download citation file:
Published: Ann Intern Med. 1989;110(10):850.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use